Most vials have a small circle or target indicating the thinnest, most easily punctured area
Testing must therefore characterize both the formulation (assay, purity, pH, osmolality, viscosity, microbial safety) and the device performance (spray pattern, plume geometry, droplet size distribution, dose uniformity, priming behavior) as an integrated system
In a 2010 clinical trial, for example, subjects who received tesamorelin ended with an average 18% decrease in visceral fat compared to placebo.27 This fat-reducing quality is what makes tesamorelin an attractive non-GLP-1 peptide option
Bottom line: Cigna Medicare Part D covers Wegovy only for the cardiovascular indication, not for weight loss alone FAQ Does Cigna Cover Wegovy for Weight Loss in 2026